These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 16623782

  • 1. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
    Watanabe K, Suzuki T.
    Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782
    [Abstract] [Full Text] [Related]

  • 2. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D, Babić D, Forko JI, Martinac I.
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [Abstract] [Full Text] [Related]

  • 3. Uterine leiomyosarcoma arising in leiomyoma: clinicopathological study of four cases and literature review.
    Yanai H, Wani Y, Notohara K, Takada S, Yoshino T.
    Pathol Int; 2010 Jul; 60(7):506-9. PubMed ID: 20594271
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of biological potential of smooth muscle tumours.
    Miettinen M, Fetsch JF.
    Histopathology; 2006 Jan; 48(1):97-105. PubMed ID: 16359541
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K.
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM, Soslow RA, Nonaka D, Olshen AB, Aghajanian C, Sabbatini P, Dupont J, Hensley M, Sonoda Y, Barakat RR, Anderson S.
    Cancer; 2004 Sep 15; 101(6):1455-62. PubMed ID: 15316901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B, Nather A, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K.
    Gynecol Oncol; 2006 Oct 15; 103(1):186-9. PubMed ID: 16595146
    [Abstract] [Full Text] [Related]

  • 10. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B, Bodner K, Czerwenka K, Kimberger O, Leodolter S, Mayerhofer K.
    Gynecol Oncol; 2005 Jan 15; 96(1):62-6. PubMed ID: 15589581
    [Abstract] [Full Text] [Related]

  • 11. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
    Atkins KA, Arronte N, Darus CJ, Rice LW.
    Am J Surg Pathol; 2008 Jan 15; 32(1):98-102. PubMed ID: 18162776
    [Abstract] [Full Text] [Related]

  • 12. Use of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcoma.
    Zhang P, Zhang C, Hao J, Sung CJ, Quddus MR, Steinhoff MM, Lawrence WD.
    Hum Pathol; 2006 Oct 15; 37(10):1350-6. PubMed ID: 16949924
    [Abstract] [Full Text] [Related]

  • 13. Fascin expression in uterine smooth muscle tumors.
    Kefeli M, Yildiz L, Kaya FC, Aydin O, Kandemir B.
    Int J Gynecol Pathol; 2009 Jul 15; 28(4):328-33. PubMed ID: 19483633
    [Abstract] [Full Text] [Related]

  • 14. Smooth muscle tumours of the uterine corpus: a clinicopathologic study with immunohistochemical aspects.
    Waldmann J, Stachs A, Terpe H, Stropahl G, Makovitzky J.
    Anticancer Res; 2005 Jul 15; 25(3A):1559-65. PubMed ID: 16033061
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
    Poncelet C, Fauvet R, Feldmann G, Walker F, Madelenat P, Darai E.
    J Surg Oncol; 2004 May 01; 86(2):84-90. PubMed ID: 15112250
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Areas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomas.
    Mittal K, Joutovsky A.
    Gynecol Oncol; 2007 Feb 01; 104(2):362-5. PubMed ID: 17011615
    [Abstract] [Full Text] [Related]

  • 18. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K, Demopoulos RI.
    Hum Pathol; 2001 Sep 01; 32(9):984-7. PubMed ID: 11567229
    [Abstract] [Full Text] [Related]

  • 19. Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features.
    Maltese G, Fontanella C, Lepori S, Scaffa C, Fucà G, Bogani G, Provenzano S, Carcangiu ML, Raspagliesi F, Lorusso D.
    Oncology; 2018 Sep 01; 94(1):1-6. PubMed ID: 28869928
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K.
    J Soc Gynecol Investig; 2004 Apr 01; 11(3):182-6. PubMed ID: 15051038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.